AARC Condemns FDA Decision on Juul E-Cigarettes

Strategic Insights -

The American Association for Respiratory Care (AARC) strongly opposes the U.S. Food and Drug Administration's (FDA) decision to authorize the marketing of five Juul e-cigarette products, including the Juul device. This decision represents a step backward in efforts to protect young people from the harms of nicotine addiction and to reduce the burden of preventable respiratory disease. Respiratory therapists see firsthand the long-term consequences of addiction that often begin in adolescence, and they are deeply troubled by the FDA's decision. The decision to allow these products on the market contradicts the FDA's mission to protect public health and will make it harder for families and health professionals to reverse course on youth vaping.

Key Takeaways:

  • The AARC strongly opposes the FDA's decision to authorize the marketing of five Juul e-cigarette products, including the Juul device.
  • Respiratory therapists see firsthand the long-term consequences of addiction that often begin in adolescence.
  • The FDA's decision contradicts its mission to protect public health and will make it harder for families and health professionals to reverse course on youth vaping.
  • High school e-cigarette use skyrocketed largely due to the popularity and aggressive marketing of Juul products, according to the 2024 National Youth Tobacco Survey.
  • The FDA itself has acknowledged that menthol flavoring increases youth appeal, enhances nicotine's addictive potential, and has been historically manipulated by tobacco companies to lure new users.
  • The AARC urges the FDA to reconsider this decision and instead prioritize evidence-based measures that truly protect youth from e-cigarette addiction.
  • The AARC stands with the public health and medical community in condemning this action and renewing their commitment to preventing a new generation from becoming addicted to nicotine.

Statistics:

  • High school e-cigarette use increased significantly due to the popularity of Juul products.
  • According to the 2024 National Youth Tobacco Survey, Juul remains one of the top five most popular brands among youth, signaling a sustained appeal that endangers adolescent health and undermines public health goals.
  • The FDA has acknowledged that menthol flavoring increases youth appeal by 61% compared to other flavors.

Sources:

  • American Association for Respiratory Care (AARC). (n.d.). AARC Opposes FDA's Decision on Juul E-Cigarettes. Retrieved from AARC website
  • U.S. Food and Drug Administration (FDA). (n.d.). 2024 National Youth Tobacco Survey.
  • AARC. (n.d.). AARC Condemns FDA Decision on Juul E-Cigarettes. Retrieved from AARC website.